{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:47:13Z","timestamp":1794577633694,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005057","name":"National Tsing Hua University","doi-asserted-by":"publisher","award":["115QF029E1"],"award-info":[{"award-number":["115QF029E1"]}],"id":[{"id":"10.13039\/501100005057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-HB-11313"],"award-info":[{"award-number":["MMH-HB-11313"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2327-B-007-001"],"award-info":[{"award-number":["NSTC114-2327-B-007-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128488","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:57:47Z","timestamp":1773856667000},"page":"128488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intranasal prime-boost immunization with trivalent influenza virus neuraminidase proteins and conserved HCA2 sequences fused to a circularly permuted E. coli heat-labile enterotoxin B subunit"],"prefix":"10.1016","volume":"79","author":[{"given":"Hao-Chan","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Wun","family":"Jheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Chin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Che","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128488_bb0005","volume":"13","author":"Bernard","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128488_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00066-1","article-title":"Probable extinction of influenza B\/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases","volume":"5","author":"Caini","year":"2024","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128488_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153183","article-title":"Influenza neuraminidase subtype N1: immunobiological properties and functional assays for specific antibody response","volume":"11","author":"Changsom","year":"2016","journal-title":"PloS One"},{"issue":"6722","key":"10.1016\/j.vaccine.2026.128488_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.adq3003","article-title":"COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses","volume":"386","author":"Chen","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128488_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786617","article-title":"Influenza neuraminidase characteristics and potential as a vaccine target","volume":"12","author":"Creytens","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128488_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of partial immunity to influenza by a neuraminidase-specific vaccine","volume":"129","author":"Couch","year":"1974","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128488_bb0035","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128488_bb0040","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1128\/JVI.01346-16","article-title":"Identification of residues that affect oligomerization and\/or enzymatic activity of influenza virus H5N1 neuraminidase proteins","volume":"90","author":"Dai","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128488_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.729914","article-title":"Tetrameric neuraminidase of influenza a virus is required to induce protective antibody responses in mice","volume":"12","author":"Deng","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128488_bb0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41467-022-29402-5","article-title":"Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination","volume":"13","author":"Dhanasekaran","year":"2022","journal-title":"Nat Commun"},{"issue":"25","key":"10.1016\/j.vaccine.2026.128488_bb0055","doi-asserted-by":"crossref","first-page":"18283","DOI":"10.1074\/jbc.M113.468884","article-title":"The universal epitope of influenza a viral neuraminidase fundamentally contributes to enzyme activity and viral replication","volume":"288","author":"Doyle","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128488_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal anti-neuraminidase antibody inhibiting all influenza a subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antivir Res"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128488_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01243-18","article-title":"Substrate binding by the second sialic acid-binding site of influenza a virus N1 neuraminidase contributes to enzymatic activity","volume":"92","author":"Du","year":"2018","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128488_bb0070","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-022-29416-z","article-title":"Structure-based design of stabilized recombinant influenza neuraminidase tetramers","volume":"13","author":"Ellis","year":"2022","journal-title":"Nat Commun"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128488_bb0075","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128488_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01160-21","article-title":"Design of the recombinant influenza neuraminidase antigen is crucial for its biochemical properties and protective efficacy","volume":"95","author":"Gao","year":"2021","journal-title":"J Virol"},{"issue":"36","key":"10.1016\/j.vaccine.2026.128488_bb0085","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.vaccine.2010.06.075","article-title":"Qualitative and quantitative analyses of virtually all subtypes of influenza a and B viral neuraminidases using antibodies targeting the universally conserved sequences","volume":"28","author":"Gravel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128488_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105978","article-title":"Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses","volume":"230","author":"Han","year":"2024","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128488_bb0095","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1021\/acsomega.5c12660","article-title":"Circular permutation of the E. coli heat-labile enterotoxin B subunit for mucosal vaccine adjuvant design","volume":"11","author":"Hsu","year":"2026","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128488_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01667-19","article-title":"Fc\u03b3 receptors contribute to the antiviral properties of influenza virus neuraminidase-specific antibodies","volume":"10","author":"Job","year":"2019","journal-title":"mBio"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128488_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01180-21","article-title":"The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses","volume":"95","author":"Kawai","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128488_bb0110","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza a virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128488_bb0115","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.chom.2023.09.012","article-title":"An atlas of continuous adaptive evolution in endemic human viruses","volume":"31","author":"Kistler","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128488_bb0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41579-021-00642-4","article-title":"Influenza lineage extinction during the COVID-19 pandemic?","volume":"19","author":"Koutsakos","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128488_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128488_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126994","article-title":"Next-generation seasonal influenza virus vaccines need a neuraminidase component","volume":"54","author":"Krammer","year":"2025","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128488_bb0135","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.immuni.2024.02.003","article-title":"Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase","volume":"57","author":"Lederhofer","year":"2024","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128488_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112766","article-title":"Boost immunizations with NA-derived peptide conjugates achieve induction of NA inhibition antibodies and heterologous influenza protections","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128488_bb0145","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza a viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128488_bb0150","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/cid\/ciz639","article-title":"Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza a(H1N1)pdm virus shedding and illness in naturally infected adults","volume":"70","author":"Maier","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128488_bb0155","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.immuni.2020.08.015","article-title":"Human antibodies targeting influenza B virus neuraminidase active site are broadly protective","volume":"53","author":"Madsen","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128488_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"McAuley","year":"2019","journal-title":"Front Microbiol"},{"issue":"45","key":"10.1016\/j.vaccine.2026.128488_bb0165","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/j.vaccine.2020.08.067","article-title":"Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice","volume":"38","author":"McMahon","year":"2020","journal-title":"Vaccine"},{"issue":"7965","key":"10.1016\/j.vaccine.2026.128488_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-023-06136-y","article-title":"A pan-influenza antibody inhibiting neuraminidase via receptor mimicry","volume":"618","author":"Momont","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128488_bb0175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"39","key":"10.1016\/j.vaccine.2026.128488_bb0180","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.39.2200753","article-title":"Has influenza B\/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?","volume":"27","author":"Paget","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128488_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127206","article-title":"Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection","volume":"57","author":"Raha","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128488_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801238-3.95721-0","article-title":"Orthomyxoviruses: structure of antigens","author":"Russell","year":"2016","journal-title":"Reference Module in Biomedical Sciences"},{"issue":"6464","key":"10.1016\/j.vaccine.2026.128488_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128488_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02241-21","article-title":"A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model","volume":"12","author":"Strohmeier","year":"2021","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128488_bb0205","article-title":"Type IIb heat labile enterotoxin B subunit as a mucosal adjuvant to enhance protective immunity against H5N1 avian influenza viruses","volume":"8","author":"Tang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128488_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126408","article-title":"Advancing influenza vaccines: a review of next-generation candidates and their potential for global health impact","volume":"42","author":"Taaffe","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128488_bb0215","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.1038\/s41467-024-53301-6","article-title":"A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128488_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.chom.2024.12.004","article-title":"Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells","volume":"33","author":"Wang","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128488_bb0225","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","article-title":"Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes","volume":"2","author":"Wohlbold","year":"2017","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128488_bb0230","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-022-34521-0","article-title":"A broadly protective human monoclonal antibody targeting the sialidase activity of influenza a and B virus neuraminidases","volume":"13","author":"Yasuhara","year":"2022","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:52:28Z","timestamp":1781308348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S0264410X26002963"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128488","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal prime-boost immunization with trivalent influenza virus neuraminidase proteins and conserved HCA2 sequences fused to a circularly permuted E. coli heat-labile enterotoxin B subunit","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128488"}}